Back to Clinical Trials Overview

Your search for "Heart" returned 57 results:


GLORIA-AF: Global Registry on Long Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (Phase II/III)
Principal Investigator(s): Emad Aziz

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,
Principal Investigator(s): Gelijns, Gelijns

A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm
Principal Investigator(s): Kim, Michael

LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function
Principal Investigator(s): Gelijns, Annetine

Cardiothoracic Surgical Trials Network
Principal Investigator(s): Gelijns, Annetine

Endothelial Function in Fibromuscular Dysplasia
Principal Investigator(s): Olin, Jeffrey W.

A Prospective Randomized Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS element) for the Treatment of up to Two De Novo Coronary Artery Lesions - PLATINUM Trial
Principal Investigator(s): Kini, Annapoorna

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial
Principal Investigator(s): Jacqueline E. Tamis-Holland

Defining the optimal dose of caudal-Epidural Morphine in Pediatric Cardiac Surgery
Principal Investigator(s): Hollinger, Ingrid

Safety and Cost Effectiveness of Same Day Dishcarge after Implantable Cardioverter-Defibrillator Implant vs Next Day Discharge
Principal Investigator(s): Emad Aziz

Multicenter, randomized, 12 week, double-blind, placebo-controlled, parallel-group, Phase IIA study using F-fluorodeoxyglucose (FDG)-PET to measure the effects of rilapladib on in-vivo macrophage activity in subjects with established atherosclerosis
Principal Investigator(s): Farkouh, Michael E.

The Vest Prevention of Early Sudden Death Trial (VEST) PREDiction of ICD Therapies (PREDICTS)
Principal Investigator(s): Skipitaris, Nicholas

Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Principal Investigator(s): Marc Miller

Chronometric Observations of Lipid Core Containing Plaques of Interest in Native Coronary Arteries Registry (COLOR Registry)
Principal Investigator(s): Kini, Annapoorna

Surgical Ablation vs No Surgical Ablation for Patients with Persistent or Longstanding Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery
Principal Investigator(s): Gelijns, Annetine

RESPOND CRT Study: Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D
Principal Investigator(s): Emad Aziz

A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety And Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation (TRYTON side-branch stent TRIAL)
Principal Investigator(s): Samin Sharma, MD

Surgical Interventions for Moderate Ischemic Mitral Regurgitation
Principal Investigator(s): Moskowitz, Alan

A non-randomized, single-blinded, open-label, investigator-initiated, pre-marketing, single-center, crossed-over Phase III clinical trial of the 12-Lead ECG Glove (12-LEG) for the assessment of cardiac electrical function. (EKG Glove Study)
Principal Investigator(s): Annapoorna Kini, MD

Rate Control versus Rhythm Control for Postoperative Atrial Fibrillation
Principal Investigator(s): Annetine Gelijns

Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy (YELLOW Trial)
Principal Investigator(s): Annapoorna Kini, MD

The Congenital Heart Disease Genetic Network Study (CHD GENES)
Principal Investigator(s): Bruce D. Gelb

Effect of Particulate Matter Exposure on Carotid Plaque Neovascularization Using Dynamic Contrast Enhances Magnetic Resonance Imaging
Principal Investigator(s): McLaughlin, Mary A

DAL Outcomes: A phase III double blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients
Principal Investigator(s): Smith, Donald A MDMPH

GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs)
Principal Investigator(s): Barry Love

A Multicenter International Phase 3 Double-Blind Placebo-Controlled Randomized Study to Evaluate the Efficacy Safety and Tolerability of Daily Oral Dosing of Tafamidis Meglumine (PF-06291826) 20 mg or 80 mg in Comparison to Placebo in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM)
Principal Investigator(s): Peter Gorevic

JOSTENT Coronary Stent Graft
Principal Investigator(s): Sharma, Samin

A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
Principal Investigator(s): Sharma, Samin

Late Sodium Current Blockade in High Risk ICD Patients (RAID Study Center #082)
Principal Investigator(s): Emad Aziz

Management Practices and the Risk of Infection Following Cardiac Surgery
Principal Investigator(s): Gelijns, Annetine

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
Principal Investigator(s): Sharma, Samin

Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation
Principal Investigator(s): Moskowitz, Alan

AMPLATZER Duct Occluder II in patients with a patent ductus arteriosus clinical study (ADO II Clinical Study)
Principal Investigator(s): Barry Love

A Randomized Clinical Trial of Intrinsic Pathway Antagonists in Patients Undergoing Implantation of Left Ventricular Assist Devices
Principal Investigator(s): Moskowitz, Alan

Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study (CIRT)
Principal Investigator(s): Zahi Fayad

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
Principal Investigator(s): Annetine Gelijns

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Principal Investigator(s): Ascheim, Deborah

WTC RENAL (Renal and Cardiovascular Impairment in WTC Responders: Implications for Diagnosis and Treatment)
Principal Investigator(s): Mary Ann McLaughlin

Model 4396 Left Ventricular Lead Clinical Study
Principal Investigator(s): Mehta, Davendra

Evaluation of the Safety and Effectiveness of the DuraHeart Left Ventricular Assist System in Patients Awaiting Transplantation
Principal Investigator(s): Parides, Michael

Genetic Markers Associated with Statin-Induced Myalgia and myopathy
Principal Investigator(s): Smith, Donald A MDMPH

Neuroprotection in Patients Undergoing Aortic Valve Replacement
Principal Investigator(s): Annetine Gelijns

SCCOR - The Effects of Intramyocardial Injection of Mesenchymal Presucursor Cells on Myocardial Function In LVAD Bridge to Transplant Patients
Principal Investigator(s): Pinney, Sean

The Vest Prevention of Early Sudden Death Trial (VEST) and VEST Registry
Principal Investigator(s): Emad Aziz

A Randomized, Open Label, Investigator-Initiated Trial comparing Intravascular Ultrasound-Guided Atherectomy to Angiography-Guided Atherectomy in Peripheral Vascular Interventions for TASC's A, B, C lesions. (UTOPIA trial)
Principal Investigator(s): Prakash Krishnan

Hormones, Sexual Well-Being & Cardiac Outcomes/Diabetics
Principal Investigator(s): McLaughlin, Mary A

The Epidemiology of Ventricular Assist Device-Related Infections
Principal Investigator(s): Parides, Michael

WTC CHEST (Pulmonary Abnormalities, Diastolic Dysfunction, and World Trade Center Exposure: Implications for Diagnosis and Treatment)
Principal Investigator(s): Mary Ann McLaughlin, MD MPH

American Legacy Smoking Cessation Study
Principal Investigator(s): Claudia I. Henschke

Coronary Assessment by Near infrared of Atherosclerotic Rupture-prone Yellow [CANARY Trial]
Principal Investigator(s): Annapoorna Kini, MD

Modified stepwise Ablation Guided by low dose Ibutilide in Chronic Atrial Fibrillation Trial (MAGIC-AF)
Principal Investigator(s): Vivek Reddy

CARES:A Prospective, Phase IV, Open-Label, Non-Randomiozed, Multicenter, Surveillance REgistry Study to Evaluate the Safety of DEFINITY in Clinical Practice
Principal Investigator(s): Goldman, Martin

A Phase 1/2 Trial of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects with Heart Failure Divided into Two Stages: Stage One Open-Label, Sequential Dose-Escalation Cohorts and Stage Two Randomized, Double-Blind, Placebo-Control, Parallel Cohorts (CUPID)
Principal Investigator(s): Kalman, Jill

RASopathy registry for individuals with a diagnosis of a RASopathy and hypertrophic cardiomyopathy
Principal Investigator(s): Bruce D. Gelb

Near Infrared Spectroscopy in Children Undergoing Congenital Heart Surgery
Principal Investigator(s): Mittnacht, Alexander

COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients
Principal Investigator(s): Davidson, Karina

Future Revascularization Evaluation in Patients with Diabetes Mellitus:Optimal Management of Multivessel Disease (FREEDOM Trial)
Principal Investigator(s): Sharma, Samin